scispace - formally typeset
J

Jennifer S Lin

Researcher at Kaiser Permanente

Publications -  96
Citations -  6366

Jennifer S Lin is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Systematic review & Medicine. The author has an hindex of 35, co-authored 86 publications receiving 5161 citations.

Papers
More filters
Journal ArticleDOI

Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

TL;DR: In randomized trials conducted among average-risk, asymptomatic women, ovarian cancer mortality did not significantly differ between screened women and those with no screening or in usual care; evidence on psychological harms was limited but nonsignificant.
Journal ArticleDOI

Screening for Colorectal Cancer : A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force

TL;DR: A targeted systematic review primarily focused on evidence gaps or new evidence since the previous review Updates what the USPSTF judged was the most important evidence for newer colorectal cancer screening tests and community-performed endoscopies and supplemented by a companion decision analysis examining screening program performance and life-years gained.
Journal ArticleDOI

Primary Care–Relevant Interventions to Prevent Falling in Older Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force

TL;DR: Primary care-relevant interventions exist that can reduce falling among community-dwelling older adults and serious clinical harms were no more common for older adults in intervention groups than for those in control groups.
Journal ArticleDOI

Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

TL;DR: Diet and physical activity behavioral interventions for adults not at high risk for cardiovascular disease result in consistent modest benefits across a variety of important intermediate health outcomes across 6 to 12 months, with evidence of a dose-response effect, with higher-intensity interventions conferring greater improvements.